Denver and New York, November 9, 2021 – Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today it has acquired a majority ownership stake in Leiters, a rapidly growing leader in the FDA-regulated 503B outsourced pharmaceutical compounding industry.
To read more about this post, click here to access the full content.
New York, New York, November 21, 2024 – Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm specializing in the technology and healthcare industries, is pleased to announce
New York, New York, November 18th, 2024 – Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused on the healthcare and technology industries, announced today that Ann
New York, NY – November 14, 2024 -- Welsh, Carson, Anderson & Stowe (“WCAS” or the “Firm”), a leading private equity firm focused exclusively on the technology and healthcare industries,
New York, October 23, 2024 – EquiLend, the global leader in technology, data, and analytics solutions for the securities finance industry, today announced the appointment of Rich Grossi as its new
New York, NY – September 19, 2024 -- Welsh, Carson, Anderson & Stowe (“WCAS” or the “Firm”), a leading private equity firm focused exclusively on the technology and healthcare industries, announced
Private equity backing to accelerate growth initiatives for EquiLend New York, September 5, 2024 – EquiLend, the global technology, data and analytics company for the securities finance industry, today announces the
